Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-10
DOI
10.1038/s41467-019-13940-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
- (2019) Egor Tchesnokov et al. Viruses-Basel
- Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
- (2019) Ariane J. Brown et al. ANTIVIRAL RESEARCH
- Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets
- (2018) Emmie de Wit et al. ANTIVIRAL RESEARCH
- Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta-analysis
- (2018) Mostafa Ebraheem Morra et al. REVIEWS IN MEDICAL VIROLOGY
- Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial
- (2018) Yaseen M. Arabi et al. Trials
- Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease
- (2018) Madeline G. Douglas et al. VIROLOGY
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase
- (2018) Paul C. Jordan et al. PLoS Pathogens
- Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection
- (2018) Megan E. Schmidt et al. PLoS Pathogens
- Correction: MERS-CoV spillover at the camel-human interface
- (2018) Gytis Dudas et al. eLife
- Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness
- (2017) Ioanna E. Galani et al. IMMUNITY
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo- and Paramyxoviruses
- (2017) Michael K. Lo et al. Scientific Reports
- IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
- (2016) Sophia Davidson et al. EMBO Molecular Medicine
- MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study
- (2016) Sun Young Cho et al. LANCET
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- Viral Load Kinetics of MERS Coronavirus Infection
- (2016) Myoung-don Oh et al. NEW ENGLAND JOURNAL OF MEDICINE
- A mouse model for MERS coronavirus-induced acute respiratory distress syndrome
- (2016) Adam S. Cockrell et al. Nature Microbiology
- Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome: a case report
- (2015) Uh Jin Kim et al. ANTIVIRAL THERAPY
- Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection
- (2015) Rudragouda Channappanavar et al. JOURNAL OF INFECTIOUS DISEASES
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
- (2015) Jasper Fuk-Woo Chan et al. JOURNAL OF INFECTIOUS DISEASES
- Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4
- (2015) Kun Li et al. JOURNAL OF INFECTIOUS DISEASES
- Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
- (2015) Marcel A Müller et al. LANCET INFECTIOUS DISEASES
- Mouse Models of Acute Respiratory Distress Syndrome
- (2015) Famke Aeffner et al. TOXICOLOGIC PATHOLOGY
- Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease
- (2015) Reed F. Johnson et al. VIROLOGY
- New Metrics for Evaluating Viral Respiratory Pathogenesis
- (2015) Vineet D. Menachery et al. PLoS One
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
- (2014) Adriaan H. de Wilde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen
- (2014) Nikolaos Spanakis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Rapid generation of a mouse model for Middle East respiratory syndrome
- (2014) Jincun Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset
- (2014) Darryl Falzarano et al. PLoS Pathogens
- Interferon- and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
- (2013) B. J. Hart et al. JOURNAL OF GENERAL VIROLOGY
- Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
- (2013) Jasper F.W. Chan et al. JOURNAL OF INFECTION
- Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
- (2013) Xing-Yi Ge et al. NATURE
- Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
- (2013) Darryl Falzarano et al. NATURE MEDICINE
- Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus
- (2013) T. Scobey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in Animals
- (2011) Gustavo Matute-Bello et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Serial Histopathological Examination of the Lungs of Mice Infected with Influenza A Virus PR8 Strain
- (2011) Masaya Fukushi et al. PLoS One
- Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy
- (2010) JS Lambert et al. HIV MEDICINE
- Estimation of inhibitory quotient using a comparative equilibrium dialysis assay for prediction of viral response to hepatitis C virus inhibitors
- (2010) H. Mo et al. JOURNAL OF VIRAL HEPATITIS
- Clinical uses of interferons
- (2008) Robert M. Friedman BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now